Hims & Hers, LifeMD Shares Soar 20+% Amid Novo Nordisk Deal for Weight-Loss Drugs
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Wednesday; Super Micro Computer, Snap to Decline
Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ
Sell Rating Maintained for Hims & Hers Health Amid Market Concerns Despite Strategic Partnership With Novo Nordisk
Earnings Preview: HIMS to Report Financial Results Post-market on May 05
Top Gap Ups and Downs on Tuesday: HON, SPOT, BBVA and More
U.S. stocks closed: the S&P 500 Index has risen for six consecutive days as investors anticipate Trump to adjust the tariff policy.
① Amazon was forced to terminate the plan to display the impact of tariffs on commodity pages; ② China Concept Stocks fluctuated, and the Nasdaq China Golden Dragon Index fell by 0.3%; ③ Meta released an independent AI application aiming to create a personalized Asia Vets assistant; ④ Starbucks reported a Q2 revenue of 8.8 billion dollars, below market expectations.
Hims & Hers Health Options Spot-On: On April 29th, 448K Contracts Were Traded, With 555.97K Open Interest
U.S. Small Caps Close Up; Hims & Hers Health Leads Increases
US Equities Markets End Higher Tuesday Despite Soft Economic Data
Why Hims & Hers Health and LifeMD Are Skyrocketing Today
TD Cowen Downgrades Hims & Hers Health(HIMS.US) to Hold Rating, Raises Target Price to $30
Citi Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $25
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $40
Express News | B of A Securities Maintains Underperform on Hims & Hers Health, Raises Price Target to $26
Top Midday Stories: Amazon Says Listing Tariff Pricing Never Considered for Main Site; Novo Nordisk Partners With Hims on Wegovy
SA Analyst Upgrades: TSLA, PYPL, QBTS, ANET, HIMS, NYT
Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday
U.S. stocks are moving | Hims & Hers Health (HIMS.US) rises over 21% after reaching a cooperation agreement with Novo-Nordisk A/S (NVO.US).
As of the time of writing, the stock has risen over 21%, trading at $34.81.
Express News | Benzinga Market Summary: Amazon Falls As White House Calls Co.'s Tariff Cost Display Plan Hostile, Hims Shares Jump On Novo Nordisk Wegovy Partnership, GM Postpones Investor Call Based On Reports Of Trade Policy Updates